Guardant Health, Inc. financial data

Symbol
GH on Nasdaq
Industry
Services-Medical Laboratories
Location
3100 Hanover Street, Palo Alto, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 620 % -0.68%
Quick Ratio 31.5 % +9.88%
Debt-to-equity 1.42K % +9.05%
Return On Equity -433 % -1.13%
Return On Assets -28.5 % +6.72%
Operating Margin -79.4 % +25.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 123M shares +4.53%
Common Stock, Shares, Outstanding 123M shares +4.51%
Entity Public Float 4.1B USD +2.5%
Weighted Average Number of Shares Outstanding, Basic 122M shares +12.5%
Weighted Average Number of Shares Outstanding, Diluted 122M shares +12.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 644M USD +26.2%
Research and Development Expense 351M USD -10.1%
Selling and Marketing Expense 310M USD +0.45%
General and Administrative Expense 153M USD -4.98%
Costs and Expenses 1.16B USD +9.54%
Operating Income (Loss) -511M USD +6.07%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -490M USD +3.26%
Income Tax Expense (Benefit) 487K USD -66.5%
Net Income (Loss) Attributable to Parent -491M USD +3.44%
Earnings Per Share, Basic -4.09 USD/shares +16.9%
Earnings Per Share, Diluted -4.09 USD/shares +16.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 934M USD +244%
Marketable Securities, Current 870M USD +97.4%
Accounts Receivable, after Allowance for Credit Loss, Current 101M USD +16.3%
Inventory, Net 67M USD +10.7%
Assets, Current 1.29B USD -7.7%
Property, Plant and Equipment, Net 132M USD -15%
Operating Lease, Right-of-Use Asset 146M USD -11.6%
Intangible Assets, Net (Excluding Goodwill) 7.74M USD -25.3%
Goodwill 3.29M USD 0%
Other Assets, Noncurrent 29.9M USD -72.2%
Assets 1.61B USD -12.5%
Accounts Payable, Current 42.4M USD -46.8%
Accrued Liabilities, Current 70.7M USD -62.5%
Contract with Customer, Liability, Current 29.4M USD +140%
Liabilities, Current 202M USD +0.32%
Contract with Customer, Liability, Noncurrent 6M USD +107%
Operating Lease, Liability, Noncurrent 172M USD -13.1%
Other Liabilities, Noncurrent 95.9M USD +915%
Liabilities 1.61B USD +4.11%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.64M USD +33.4%
Retained Earnings (Accumulated Deficit) -2.36B USD -26.3%
Stockholders' Equity Attributable to Parent -1.61M USD -101%
Liabilities and Equity 1.61B USD -12.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.3M USD +59.3%
Net Cash Provided by (Used in) Financing Activities -1.07M USD -25.8%
Net Cash Provided by (Used in) Investing Activities 28.1M USD -82.1%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 123M shares +4.51%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.43M USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.04B USD +282%
Deferred Tax Assets, Valuation Allowance 604M USD +23.5%
Deferred Tax Assets, Gross 654M USD +22.4%
Operating Lease, Liability 200M USD -10.4%
Depreciation 40.6M USD +6.56%
Payments to Acquire Property, Plant, and Equipment 6.93M USD -7.84%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -659M USD -50.2%
Lessee, Operating Lease, Liability, to be Paid 229M USD -11.9%
Property, Plant and Equipment, Gross 279M USD +6.12%
Operating Lease, Liability, Current 27.7M USD +12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 28.1M USD -13.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 33.2M USD -1.25%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 28.8M USD -21.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 24.5M USD -11.9%
Deferred Tax Assets, Operating Loss Carryforwards 344M USD +16.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 36.9M USD +24.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.3M USD -4.73%
Additional Paid in Capital 2.36B USD +8.92%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2.6M USD -7.14%
Depreciation, Depletion and Amortization 10.7M USD +3.55%
Deferred Tax Assets, Net of Valuation Allowance 1.05M USD +107%
Share-based Payment Arrangement, Expense 100M USD +12.9%
Interest Expense 2.58M USD +0.08%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%